Brighton Jones LLC’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,230
Closed -$5.73K 579
2023
Q2
$5.73K Hold
1,230
﹤0.01% 545
2023
Q1
$5.73K Hold
1,230
﹤0.01% 517
2022
Q4
$5.54K Hold
1,230
﹤0.01% 475
2022
Q3
$22K Hold
1,230
﹤0.01% 459
2022
Q2
$62K Hold
1,230
﹤0.01% 459
2022
Q1
$173K Hold
1,230
0.01% 490
2021
Q4
$210K Hold
1,230
0.01% 490
2021
Q3
$613K Buy
1,230
+662
+117% +$307K 0.03% 235
2021
Q2
$285K Sell
568
-662
-54% -$356K 0.01% 359
2021
Q1
$624K Sell
1,230
-100
-8% -$51.6K 0.04% 205
2020
Q4
$634K Buy
1,330
+167
+14% +$54.8K 0.04% 180
2020
Q3
$334K Buy
1,163
+498
+75% +$123K 0.02% 241
2020
Q2
$127K Buy
665
+2
+0.3% +$333 0.01% 284
2020
Q1
$83K Buy
663
+143
+28% +$25.9K 0.01% 267
2019
Q4
$91K Buy
520
+185
+55% +$23.9K 0.01% 313
2019
Q3
$50K Hold
335
0.01% 303
2019
Q2
$39K Hold
335
﹤0.01% 304
2019
Q1
$57K Hold
335
0.01% 297
2018
Q4
$40K Hold
335
0.01% 256
2018
Q3
$51K Buy
335
+50
+18% +$20.9K 0.01% 278
2018
Q2
$188K Hold
285
0.02% 288
2018
Q1
$291K Buy
285
+183
+179% +$153K 0.04% 212
2017
Q4
$124K Hold
102
0.02% 284
2017
Q3
$19K Hold
102
﹤0.01% 293
2017
Q2
$16K Buy
+102
New +$20.6K ﹤0.01% 274

Other funds holding AMPE

Brighton Jones LLC's AMPE Position: Q3 2023 in Review

Brighton Jones LLC sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2023, closing a stake of 1,230 shares — an estimated $5.73K sold.

Brighton Jones LLC first reported a position in AMPE in Q2 2017 and held it in 25 quarters. The position peaked at $634K in Q4 2020. 26 funds tracked by Wall St. Rank hold AMPE as of Q3 2023.

  • Brighton Jones LLC reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2023 after selling out during the quarter.
  • Brighton Jones LLC sold 1,230 Ampio Pharmaceuticals Inc. shares in Q3 2023, an estimated $5.73K.
  • Brighton Jones LLC first reported a position in Ampio Pharmaceuticals Inc. in Q2 2017 and held it in 25 quarters.
  • Brighton Jones LLC's Ampio Pharmaceuticals Inc. position peaked at $634K in Q4 2020.
  • 26 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2023.

Based on Brighton Jones LLC's 13F filing for Q3 2023, filed 26 Oct 2023.